X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6907) 6907
Publication (1465) 1465
Book Review (141) 141
Book Chapter (59) 59
Conference Proceeding (31) 31
Magazine Article (6) 6
Book / eBook (5) 5
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3831) 3831
index medicus (3577) 3577
humans (3427) 3427
male (2824) 2824
pharmacology & pharmacy (2575) 2575
neurosciences (2125) 2125
nicotine (2000) 2000
rats (1708) 1708
female (1674) 1674
nicotinic agonists - pharmacology (1398) 1398
nicotinic agonists - therapeutic use (1284) 1284
nicotine - pharmacology (1272) 1272
receptors, nicotinic - metabolism (1162) 1162
psychiatry (1132) 1132
mice (1076) 1076
article (966) 966
adult (946) 946
dose-response relationship, drug (936) 936
smoking (911) 911
smoking cessation - methods (836) 836
nicotine - administration & dosage (777) 777
rats, sprague-dawley (766) 766
nicotinic agonists - administration & dosage (760) 760
smoking cessation (757) 757
middle aged (719) 719
varenicline (688) 688
receptors, nicotinic - drug effects (683) 683
nicotine - therapeutic use (633) 633
nicotinic acetylcholine-receptors (624) 624
analysis (587) 587
nicotinic antagonists - pharmacology (574) 574
brain (541) 541
acetylcholine (540) 540
nicotinic receptors (527) 527
cigarette-smoking (510) 510
receptors (505) 505
schizophrenia (500) 500
receptors, nicotinic - physiology (498) 498
acetylcholine-receptors (490) 490
treatment outcome (477) 477
acetylcholine receptors (475) 475
nicotinic acetylcholine-receptor (451) 451
biomedicine (446) 446
research (437) 437
time factors (429) 429
rodents (416) 416
disease models, animal (408) 408
neurons (397) 397
benzazepines - therapeutic use (396) 396
quinoxalines - therapeutic use (393) 393
pharmacology (392) 392
alzheimers-disease (385) 385
dopamine (382) 382
smoking-cessation (380) 380
receptors, nicotinic - genetics (377) 377
pharmacology/toxicology (375) 375
smoking cessation programs (373) 373
tobacco (364) 364
nicotinic agonists - adverse effects (361) 361
biochemistry & molecular biology (358) 358
substance abuse (353) 353
clinical neurology (352) 352
health aspects (350) 350
nicotinic acetylcholine receptor (349) 349
smokers (349) 349
brain - drug effects (344) 344
rats, wistar (344) 344
brain - metabolism (336) 336
mice, inbred c57bl (335) 335
nicotinic acetylcholine receptors (324) 324
ligands (322) 322
alpha7 nicotinic acetylcholine receptor (321) 321
nervous system (321) 321
alzheimer's disease (320) 320
double-blind method (320) 320
rat (318) 318
addiction (310) 310
physiological aspects (307) 307
tobacco use disorder - drug therapy (306) 306
adolescent (300) 300
nicotinic receptor (300) 300
aged (299) 299
behavior, animal - drug effects (296) 296
behavioral sciences (296) 296
bupropion - therapeutic use (295) 295
ventral tegmental area (292) 292
mecamylamine - pharmacology (291) 291
care and treatment (288) 288
sustained-release bupropion (280) 280
inflammation (279) 279
toxicology (279) 279
in vitro techniques (278) 278
nicotine - adverse effects (276) 276
neurology (275) 275
receptor partial agonist (269) 269
nicotine replacement therapy (267) 267
proteins (267) 267
young adult (267) 267
cessation (265) 265
smoking prevention (265) 265
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6836) 6836
French (32) 32
Spanish (23) 23
German (20) 20
Japanese (10) 10
Polish (6) 6
Dutch (5) 5
Chinese (4) 4
Danish (3) 3
Czech (2) 2
Hungarian (2) 2
Romanian (2) 2
Russian (2) 2
Swedish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 08/2008, Volume 165, Issue 8, pp. 1040 - 1047
Journal Article